Merdad Parsey - 28 Apr 2025 Form 4 Insider Report for ArriVent BioPharma, Inc. (AVBP)

Role
Director
Signature
/s/ James Kastenmayer, Attorney-in-Fact for Merdad Parsey
Issuer symbol
AVBP
Transactions as of
28 Apr 2025
Net transactions value
$0
Form type
4
Filing time
29 Apr 2025, 16:51:43 UTC
Previous filing
11 Dec 2024
Next filing
23 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVBP Stock Option (right to buy) Award $0 +28,346 $0.000000 28,346 28 Apr 2025 Common Stock 28,346 $20.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options vest annually in equal installments over three years, subject to the Reporting Person's continued service through the applicable vesting date.